Finding a study
According to a recent study lead by ResearchersAgainstAlzheimer’s (RA2) the number of clinical trials evaluating possible treatments against Alzheimer’s disease is on the rise. The results of this study called « Where are we on the path 2025 » were presented at UsAgaintsAlzheimer summit held in Washington D.C last September.
To date 57 clinical trials are either in phase II or III, with 19 promising molecules that could reach the market within 5 years. It’s very encouraging to see that the number of phase II tested drugs is so important, with various therapeutic approach, which give us a real hope in the future.
With this new challenge, patient recruitment is more important than ever. We have a duty to help them make the best choice for themselves and their loved ones by knowing all the advantages of being involved in a study but also evaluating potential risks related to clinical trials.
The Federation of Quebec Alzheimer Societies decided to support several research initiatives:
To know more about ongoing clinical trials in Quebec and in Canada, here are useful links:
- Clinical Trial simplified: Their mission is to help every patient find a clinical trial that matches his medical condition. Several studies are already recruiting!
Last Updated: 01/20/17